197 related articles for article (PubMed ID: 34658136)
1. An Open-Label Study Assessing the Efficacy and Tolerability of a Skincare Regimen in Subjects of Different Ethnicities with Moderate-to-Severe Hyperpigmentation.
Wenner K; Ramberg T
J Cosmet Dermatol; 2022 Jun; 21(6):2497-2507. PubMed ID: 34658136
[TBL] [Abstract][Full Text] [Related]
2. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
Serra M; Bohnert K; Narda M; Granger C; Sadick N
J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of novel topical pigment-correcting regimen with biweekly diamond tip microdermabrasion procedures on facial hyperpigmentation.
Goberdhan L; Schneider K; Makino ET; Bautista A; Mehta RC
J Cosmet Dermatol; 2024 May; 23(5):1726-1733. PubMed ID: 38288515
[TBL] [Abstract][Full Text] [Related]
4. Open-label study assessing the efficacy and tolerability of topical skincare and sun protection products following intense pulsed light treatment.
Jones IT; Guiha I; Fabi SG
J Cosmet Dermatol; 2018 Jun; 17(3):441-447. PubMed ID: 29164778
[TBL] [Abstract][Full Text] [Related]
5. Two-Step Skincare Regimen Addressing Aging in Three Unique Geographic Locations: A Prospective, Multi-Center, Open-Label Study.
Cohen J; Palm M; Biesman B; Young M; Kononov T; Zahr A
J Drugs Dermatol; 2023 Jan; 22(1):16-22. PubMed ID: 36607762
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
Rendon MI; Barkovic S
J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
Fabi SG; Goldman MP
J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
[TBL] [Abstract][Full Text] [Related]
8. Effects of a Topical Growth Factor Regimen Following Pre-elected Cosmetic Facial Injection Procedures.
Goldman M; Boen M; Deaver J; Makino E; Mehta R
J Drugs Dermatol; 2023 Jan; 22(1):9-15. PubMed ID: 36607755
[TBL] [Abstract][Full Text] [Related]
9. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
[TBL] [Abstract][Full Text] [Related]
11. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
[TBL] [Abstract][Full Text] [Related]
12. Novel Facial Treatment Regimen Improves Aging Skin Appearance.
Farris P; Draelos ZD; Felipe de Oliveira Stehling L
J Drugs Dermatol; 2021 Mar; 20(3):274-278. PubMed ID: 33683078
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Circadian-based Antioxidants Plus a Comprehensive Brightener in Skin of Color Patients With Hyperpigmentation.
Desai S; Manry S; Makino E; Mehta R
J Drugs Dermatol; 2022 Apr; 21(4):376-380. PubMed ID: 35389588
[TBL] [Abstract][Full Text] [Related]
14. Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.
Philipp-Dormston WG; Vila Echagüe A; Pérez Damonte SH; Riedel J; Filbry A; Warnke K; Lofrano C; Roggenkamp D; Nippel G
Int J Cosmet Sci; 2020 Aug; 42(4):377-387. PubMed ID: 32390164
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment of a circadian-based antioxidant system combined with a comprehensive brightening serum in diverse subjects with moderate-to-severe facial hyperpigmentation.
Shah S; Manry S; Makino ET; Mehta RC
J Cosmet Dermatol; 2022 May; 21(5):2082-2088. PubMed ID: 35287252
[TBL] [Abstract][Full Text] [Related]
16. Pigmentation control in pregnancy-induced melasma: Clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum.
Makino ET; Jiang LI; Stephens TJ; Mikati M; Mehta RC
J Cosmet Dermatol; 2022 Nov; 21(11):5739-5746. PubMed ID: 35708506
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
18. Effect of glycolic acid, phytic acid, soothing complex containing Emulsion on Hyperpigmentation and skin luminosity: A clinical evaluation.
Houshmand EB
J Cosmet Dermatol; 2021 Mar; 20(3):776-780. PubMed ID: 33458927
[TBL] [Abstract][Full Text] [Related]
19. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women With Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin.
Herndon JH; Jiang LI; Kononov T; Fox T
J Drugs Dermatol; 2016 Apr; 15(4):476-82. PubMed ID: 27050703
[TBL] [Abstract][Full Text] [Related]
20. Open-Label assessment of the efficacy and tolerability of a skin care regimen for treating subjects with visible and physical symptoms of sensitive skin.
Turner EO
J Cosmet Dermatol; 2022 Sep; 21(9):3876-3887. PubMed ID: 35639491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
